Daily Health Headlines

New Treatments Helping Kids With Juvenile Arthritis

👤by Mary Elizabeth Dallas 0 comments 🕔Thursday, July 21st, 2016

WEDNESDAY, July 20, 2016 (HealthDay News) -- New treatments for juvenile arthritis offer hope to children with the chronic autoimmune condition, doctors say.

Scientists are still working to understand what causes juvenile arthritis and how to stop its progression. But, kids coping with its effects have reason to be optimistic, according to Dr. Nikolay Nikolov, a rheumatologist and clinical team leader at the U.S. Food and Drug Administration.

"We don't have a cure for juvenile arthritis -- we're not there yet," Nikolov said in an FDA news release. "But we're making progress."

But it's important to note that the drugs aren't risk-free.

Juvenile arthritis is one of the most common chronic childhood conditions, affecting nearly 300,000 children in the United States, according to the FDA.

The disease causes the immune system to attack its own tissues, resulting in pain, swelling, tenderness and stiffness in the joints. These symptoms usually begin before children are 16 years old.

There are several types of juvenile arthritis, known collectively as Juvenile Idiopathic Arthritis (JIA). JIA can involve the knees, wrists and ankles as well as smaller joints, according to the FDA.

The largest subtype of JIA is known as polyarticular JIA, which affects many joints. Systemic JIA is another subtype that affects the entire body, triggering fevers and rashes, the agency explained.

New treatments can help. In the past, children with the condition were given drugs to suppress their immune system or medications to ease inflammation, including aspirin and ibuprofen.

More recently, however, drugs extracted from biological sources -- called biologics -- have become available to treat polyarticular and systemic JIA. Different biologics tend to work better for different subtypes of the disease, Nikolov said.

Among the biologics approved by the FDA since 1999 for treatment of polyarticular JIA are Humira (adalimumab); Orencia (abatacept); Enbrel (etanercept); and Actemra (tocilizumab).

Biologics approved since 2011 for treatment of systemic JIA are Actemra and Ilaris (canakinumab).

These medications are typically injected under the skin or given intravenously. Children usually take them for years.

The treatments target specific molecules in the body that trigger inflammation called cytokines, and other naturally occurring proteins that stimulate the immune system, according to Nikolov.

But biologics are powerful drugs that suppress the immune system and can increase children's risk of serious infections, including tuberculosis. The FDA weighs these risks and whether the potential benefits of the drugs for children with juvenile arthritis outweigh them, Nikolov said.

"It's possible that safety issues might come up in kids that we have not found in adults," he said. "For example, these drugs may affect the developing body and immune system in children, and that may warrant changes in the labels to let both health care providers and patients know what are the risks involved, and how to recognize and respond to potential problems."

-- Mary Elizabeth Dallas

Article Credits / Source

Mary Elizabeth Dallas / HealthDay

Mary Elizabeth Dallas wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: U.S. Food and Drug Administration, news release, July 14, 2016

View More Articles From Mary Elizabeth Dallas 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Arthritis Articles

Delays in Lupus Care Seen Among Minorities, Less Educated

Delays in Lupus Care Seen Among Minorities, Less Educated0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Delays in lupus treatment are more common among Americans who are black, Asian or are less educated, a new study finds. Lupus is a chronic autoimmune disease in which inflammation affects the skin, ...

Having Rheumatoid Arthritis May Increase Heart Risk

Having Rheumatoid Arthritis May Increase Heart Risk0

TUESDAY, Nov. 15, 2016 (HealthDay News) -- People with rheumatoid arthritis may have an increased risk for a heart attack, stroke and other heart disease-related problems, a new study suggests. Researchers examined data from 353 rheumatoid ...

Rheumatoid Factor (RF)

Rheumatoid Factor (RF)0

What Is Rheumatoid Arthritis (RA)? Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly attacked by their own ...

Health Tip: Keep Psoriatic Arthritis Fatigue in Check

Health Tip: Keep Psoriatic Arthritis Fatigue in Check0

(HealthDay News) -- Fatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have moderate-to-severe fatigue. The ...

Osteoarthritis Symptoms

Osteoarthritis Symptoms0

Comment by William C. Shiel Jr., MD, FACP, FACR Common osteoarthritis symptoms and signs Symptoms of osteoarthritis vary greatly from patient to patient and they depend on the severity of cartilage loss and the joint(s) affected. Many people ...

View More Arthritis Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!